Drug Monitoring Phencyclidine Screen, Urine
Also known as: Prescription Drug Monitoring, Pain Management
Use
This test screens urine for the presence of phencyclidine (PCP), a dissociative hallucinogenic drug, to detect recent use. It is designed as an initial screening assay; confirmatory testing using mass spectrometry (e.g., GC‑MS or LC‑MS/MS) may be indicated following a presumptive positive result for definitive identification.
Special Instructions
Not provided.
Limitations
As a screening assay, this test may produce false positive results; confirmatory testing is recommended for any positive findings. Urine drug detection windows are limited and may not reflect ingestion beyond the recent exposure period (typically 24–72 hours). Cross-reactivity or substance interference is possible depending on the assay's specificity.
Methodology
Not provided.
Biomarkers
Not provided.
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
Not provided
Minimum Volume
Not provided